etoposide has been researched along with Pharyngeal Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, YJ; Cha, W; Choi, BS; Kim, H | 1 |
| Byun, MR; Choi, JW; Kim, YR; Lee, B; Lee, JK | 1 |
| Saleh, EM | 1 |
| Ichikawa, G; Kohno, N; Kusunoki, M; Nakazawa, E; Nishiya, M | 1 |
| Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S | 1 |
| Löhr, G; Musil, J; Nagel, GA; Rauschning, W; Schröder, M; Schuff-Werner, P | 1 |
1 trial(s) available for etoposide and Pharyngeal Neoplasms
| Article | Year |
|---|---|
[Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunotherapy; Longitudinal Studies; Lymphocytes; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Thymus Extracts | 1987 |
5 other study(ies) available for etoposide and Pharyngeal Neoplasms
| Article | Year |
|---|---|
Primary pharyngeal synovial sarcoma in a pediatric patient: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Deglutition Disorders; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Multimodal Imaging; Pharyngeal Neoplasms; Reoperation; Sarcoma, Synovial; Vincristine | 2021 |
Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Screening Assays, Antitumor; Etoposide; Humans; Mouth Neoplasms; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Pemetrexed; Pharyngeal Neoplasms | 2018 |
Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair.
Topics: Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Pharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Topoisomerase II Inhibitors | 2015 |
Induction chemotherapy with cisplatin, etoposide, and mitomycin-C (PEM) regimen in advanced cases with cancer of pharynx and oral cavity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction | 1995 |
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction | 1992 |